Nicotine vaccines move toward pivotal trials.
McNeil
Caroline
C
D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D009538:Nicotine / Q000276:immunology*; D016032:Randomized Controlled Trials as Topic; D011978:Receptors, Nicotinic / Q000276:immunology*; D016540:Smoking Cessation / Q000379:methods*; D014612:Vaccines / Q000627:therapeutic use*
D011978:Receptors, Nicotinic; D014612:Vaccines; D009538:Nicotine